- Home
- Industry Reports
- Biotechnology
- Healthcare
- Global Precision Medicine Market- Share, Outlook, Trends, Size and Forecast (2023 – 2030)
Precision medicine is a medical approach that helps in the treatment by providing customised medicine based on their medical decisions, practices, and allows doctors and physicians to study the individual response to a medication. Precision medicine is also known as personalised medicine. Precision Medicine Market is accounted for USD XX billion in 2017 and expected to grow at a CAGR of X% to reach USD XX billion by 2024.
Precision Medicine Market share:
Precision Medicine market is segmented by type of technology, application, and geography. On basics of applications, the most substantial percentage is in North America especially the US. Because of the awareness campaigns and innovative solutions for chronic diseases like cancer has raised the precision medicine market share.
Precision Medicine Market size:
The innovative solutions to chronic diseases, genetic disorders have massively driven the marketplace in North America, followed by Europe. During the forecast period, Asia-Pacific is going to have the highest growth rate in the precision medicine market.
Precision Medicine Market growth:
The market for precision medicine is driven by factors such as personalised treatments, technology developments, improving cancer treatment techniques, and efforts to define genes are raising the overall growth of the precision medicine market.
Precision Medicine Market Industrial Analysis:
Precision Medicine Market is segmented by the type of technology, applications, and geography. In this categorisation, the growth of the market is driven by technology segment classified by bioinformatics, drug discovery and big data analytics. Because of combining therapies and study of drugs resistance drug discovery has the fastest growth in the market.
.Precision Medicine Market Outlook:
Precision medicines are primarily used in diagnosis and treatment of diseases based on genetics, and in research on various chronic diseases especially on oncology for instance, in pharmaceutical companies have further increased the demand for precision medicine across different healthcare verticals and its predominant in North America especially the US.
Precision Medicine Market Trends:
Cardinal Health has completed the acquisition of Medtronic’s Patient Care, Deep Vein Thrombosis and Nutritional Insufficiency business in July 2017.
Bayer AG Inc., Loxo Oncology‘s, and Roche Holdings is acquiring Ignyta, a company which is exploring different approaches to cancer treatment in December 2017.
Precision Medicine Market Research Reports:
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have complete market analysis through industry value chain analysis, Porter’s five, PESTLE, SWOT analysis, and Y-o-Y analysis.
- Regional and global diversity is analysed with the major countries and the unions.
- Scrutinizing the revenue generation on Year–On–Year
- Identifying DROC in the current market and their impact in altering the market dynamics.
- Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
- Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Identify the latest developments, market shares and strategies that are employed by the major market players, such as:
- Eagle Genomics
- Covance
- Source Precision Medicine
- Laboratory Corporation of America Holdings
- Medtronic
Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter’s Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1 DROC
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
Chapter 5 Market Segmentation Analysis
Chapter 6 Market Segmentation by Type of Technology
6.1 Bioinformatics
6.2 Drug Discovery
6.3 Gene Sequencing
6.4 Big Data Analytics
6.5 Companion Diagnostics
6.6 Pharmacogenomics
Chapter 7 Market Segmentation by Applications
7.1 Immunology
7.2 Respiratory
7.3 Neurology
7.4 Cardiology
7.5 CNS
Chapter 8 Market Segmentation by Geography
8.1 North America
8.1.1 Introduction
8.1.2 United States
8.1.3 Canada
8.1.4 Mexico
8.1.5 Others
8.2 Europe
8.2.1 Introduction
8.2.2 Spain
8.2.3 UK
8.2.4 France
8.2.5 Russia
8.2.6 Italy
8.2.7 Others
8.3 Asia Pacific
8.3.1 Introduction
8.3.2 China
8.3.3 India
8.3.4 Japan
8.3.5 Australia
8.3.6 Others
8.4 The Middle East and Africa
8.4.1 Introduction
8.4.2 South Africa
8.4.3 Middle East Countries
8.4.4 Others
8.5 South America
8.5.1 Introduction
8.5.2 Argentina
8.5.3 Brazil
8.5.5 Others
Chapter 9 Competitive Landscape
9.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
9.2 Market Share Analysis
9.3 Strategies Adopted By Top Companies
Chapter 10 Company Profiles
10.1 Nanostring Technologies
10.1.1. Company Overview
10.1.2. Financial Performance
10.1.3. Product Benchmarking
10.1.4. Strategic Initiative
10.2 Roche Holding
10.3 Intomics
10.4 Biocrates Life Sciences
10.5 Silicon Biosystems
10.6 Ferrer InCode
10.7 Pfizer
10.8 Tepnel Pharma Services
10.9 Eagle Genomics
10.10 Covance
10.11 Source Precision Medicine
10.12 Laboratory Corporation of America Holdings
10.13 Medtronic
10.14 Quest Diagnostics
10.15 Teva Pharmaceuticals
Chapter 11 Market Estimates and Forecasting
11.1 Market Estimates and Forecasting 2018-2024(USD Million)
11.1.1 Market Estimation and Forecasting by Type of Technology 2018-2024 (USD Million)
11.1.2 Market Estimates and Forecasting by Application 2018-2024 (USD Million)
11.1.3 Market Estimates and Forecasting by Geography 2018-2024 (USD Million)
11.1.4 Market Estimates and Forecasting by Company 2018-2024 (USD Million)
Chapter 12 Market Insights
12.1 Insights of Industry Experts
12.2 Analyst Opinion (Market Understanding)
12.3 Investment Opportunities
Chapter 13 Appendix
13.1 List of Tables
13.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Global Report
$2,700.00 – $8,100.00
- EUR: €2,497.46 - €7,492.37
- INR: ₹225,111.97 - ₹675,335.91
- AED: د.إ9,909.00 - د.إ29,727.00
- GBP: £2,135.57 - £6,406.72
Additional information
Report Type | Extensive Report, Miniature report, Snapshot Report |
---|---|
Licence | Single User License, Team License, Corporate License |
Precision medicine is a medical approach that helps in the treatment by providing customised medicine based on their medical decisions, practices, and allows doctors and physicians to study the individual response to a medication. Precision medicine is also known as personalised medicine. Precision Medicine Market is accounted for USD XX billion in 2017 and expected to grow at a CAGR of X% to reach USD XX billion by 2024.
Precision Medicine Market share:
Precision Medicine market is segmented by type of technology, application, and geography. On basics of applications, the most substantial percentage is in North America especially the US. Because of the awareness campaigns and innovative solutions for chronic diseases like cancer has raised the precision medicine market share.
Precision Medicine Market size:
The innovative solutions to chronic diseases, genetic disorders have massively driven the marketplace in North America, followed by Europe. During the forecast period, Asia-Pacific is going to have the highest growth rate in the precision medicine market.
Precision Medicine Market growth:
The market for precision medicine is driven by factors such as personalised treatments, technology developments, improving cancer treatment techniques, and efforts to define genes are raising the overall growth of the precision medicine market.
Precision Medicine Market Industrial Analysis:
Precision Medicine Market is segmented by the type of technology, applications, and geography. In this categorisation, the growth of the market is driven by technology segment classified by bioinformatics, drug discovery and big data analytics. Because of combining therapies and study of drugs resistance drug discovery has the fastest growth in the market.
.Precision Medicine Market Outlook:
Precision medicines are primarily used in diagnosis and treatment of diseases based on genetics, and in research on various chronic diseases especially on oncology for instance, in pharmaceutical companies have further increased the demand for precision medicine across different healthcare verticals and its predominant in North America especially the US.
Precision Medicine Market Trends:
Cardinal Health has completed the acquisition of Medtronic’s Patient Care, Deep Vein Thrombosis and Nutritional Insufficiency business in July 2017.
Bayer AG Inc., Loxo Oncology‘s, and Roche Holdings is acquiring Ignyta, a company which is exploring different approaches to cancer treatment in December 2017.
Precision Medicine Market Research Reports:
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have complete market analysis through industry value chain analysis, Porter’s five, PESTLE, SWOT analysis, and Y-o-Y analysis.
- Regional and global diversity is analysed with the major countries and the unions.
- Scrutinizing the revenue generation on Year–On–Year
- Identifying DROC in the current market and their impact in altering the market dynamics.
- Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
- Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Identify the latest developments, market shares and strategies that are employed by the major market players, such as:
- Eagle Genomics
- Covance
- Source Precision Medicine
- Laboratory Corporation of America Holdings
- Medtronic
Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter’s Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1 DROC
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
Chapter 5 Market Segmentation Analysis
Chapter 6 Market Segmentation by Type of Technology
6.1 Bioinformatics
6.2 Drug Discovery
6.3 Gene Sequencing
6.4 Big Data Analytics
6.5 Companion Diagnostics
6.6 Pharmacogenomics
Chapter 7 Market Segmentation by Applications
7.1 Immunology
7.2 Respiratory
7.3 Neurology
7.4 Cardiology
7.5 CNS
Chapter 8 Market Segmentation by Geography
8.1 North America
8.1.1 Introduction
8.1.2 United States
8.1.3 Canada
8.1.4 Mexico
8.1.5 Others
8.2 Europe
8.2.1 Introduction
8.2.2 Spain
8.2.3 UK
8.2.4 France
8.2.5 Russia
8.2.6 Italy
8.2.7 Others
8.3 Asia Pacific
8.3.1 Introduction
8.3.2 China
8.3.3 India
8.3.4 Japan
8.3.5 Australia
8.3.6 Others
8.4 The Middle East and Africa
8.4.1 Introduction
8.4.2 South Africa
8.4.3 Middle East Countries
8.4.4 Others
8.5 South America
8.5.1 Introduction
8.5.2 Argentina
8.5.3 Brazil
8.5.5 Others
Chapter 9 Competitive Landscape
9.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
9.2 Market Share Analysis
9.3 Strategies Adopted By Top Companies
Chapter 10 Company Profiles
10.1 Nanostring Technologies
10.1.1. Company Overview
10.1.2. Financial Performance
10.1.3. Product Benchmarking
10.1.4. Strategic Initiative
10.2 Roche Holding
10.3 Intomics
10.4 Biocrates Life Sciences
10.5 Silicon Biosystems
10.6 Ferrer InCode
10.7 Pfizer
10.8 Tepnel Pharma Services
10.9 Eagle Genomics
10.10 Covance
10.11 Source Precision Medicine
10.12 Laboratory Corporation of America Holdings
10.13 Medtronic
10.14 Quest Diagnostics
10.15 Teva Pharmaceuticals
Chapter 11 Market Estimates and Forecasting
11.1 Market Estimates and Forecasting 2018-2024(USD Million)
11.1.1 Market Estimation and Forecasting by Type of Technology 2018-2024 (USD Million)
11.1.2 Market Estimates and Forecasting by Application 2018-2024 (USD Million)
11.1.3 Market Estimates and Forecasting by Geography 2018-2024 (USD Million)
11.1.4 Market Estimates and Forecasting by Company 2018-2024 (USD Million)
Chapter 12 Market Insights
12.1 Insights of Industry Experts
12.2 Analyst Opinion (Market Understanding)
12.3 Investment Opportunities
Chapter 13 Appendix
13.1 List of Tables
13.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Our Clientele
Exclusive Benefits
Credibility and Transparency
We actively recruit consumers, business professionals, and hard-to-reach individuals as members of our research panels, and we build trusted, ongoing relationships with them. Thus we provide the complete list of primary and secondary data sources in the report to maintain the transparency and to assure the credibility.
Exhaustive Coverage
Detailed and extensive coverage in the geography.Survey consultation for brand tracking, concept testing, consumer behaviour, and more, we have you covered with market research services that scale to meet your needs.
Competitive Edge
Our reports cover most recent updates in the market till the date of the purchase. We identify, gather and timely deliver analysis on impact of unprecedented decisions of CXOs in COVID-19 catastrophe on many businesses, their clients and their clients' clients without additional cost.
Golden Opportunities
A comprehensive strategic sieve analysis of the market by our analysts and consultants, aided by AI tools helps us find the non-obvious, golden and emerging opportunities for you to evaluate.
Top-notch Reports Guaranteed
70% of our research is exclusive; no other research firm has the depth and breadth of our research.
Post Purchase Support
Post-purchase support is provided for all our reports, for three months from the date of purchase, where related queries will be answered within 24 business hours over telephone or email.